Active Clinical Trials

25 clinical trials currently in progress for PKD — including drug candidates, metabolic interventions, and lifestyle studies.

Drug Trials (16)

Pharmaceutical compounds in clinical trials for PKD

ABBV-CLS-628

Calico Life Sciences / AbbVie • Phase 2 • ANCHOR

Recruiting

Atorvastatin

Taipei Medical University Shuang Ho Hospital • Phase 2 • Atorvastatin + Sodium Bicarbonate Pilot

Enrolling by Invitation

AZD1613

AstraZeneca • Phase 1 • PIONEER-PKD

Recruiting

Bempedoic Acid

University of Vermont (DoD-funded) • Phase 2 • BEAT-PKD

Not Yet Recruiting

Dapagliflozin

University of Cologne • Phase 3 • STOP-PKD

Recruiting

Empagliflozin

Multiple Sponsors • Phase 2 • EMPA-PKD / SIDIA / Colorado Feasibility

Active, Not Recruiting

Farabursen (CYX082)

Novartis (acquired Regulus Therapeutics) • Phase 3 • Phase 3 Registrational Trial

Not Yet Recruiting

GSK4771261

GlaxoSmithKline • Phase 1 • Phase 1a/1b Single Ascending Dose

Active, Not Recruiting

Hydrochlorothiazide

University Medical Center Groningen • Phase 3 • HYDRO-PROTECT

Recruiting

JMKX003142

Jemincare • Phase 2 • Phase 2 ADPKD

Recruiting

Metformin

University of Queensland • Phase 3 • IMPEDE-PKD

Recruiting

PYC-003

PYC Therapeutics • Phase 1 • First-in-Human PKD1

Recruiting

Rotigotine

University Hospital Rouen • Phase 2 • ETERNAL-PKD

Recruiting

Tamibarotene

Rege Nephro Co., Ltd. • Phase 2 • Phase 2a ADPKD

Active, Not Recruiting

Tirzepatide

University of Colorado Denver • Phase 2 • Tirzepatide in Overweight ADPKD

Recruiting

VX-407

Vertex Pharmaceuticals • Phase 2 • AGLOW

Active, Not Recruiting

Therapy & Lifestyle Trials (5)

Non-drug interventional studies for PKD

Metabolic Intervention Trials (4)

Ketogenic and metabolic studies with ongoing enrollment or interim results

Stay Updated on PKD Research

Get notified when new drugs enter clinical trials, trial results are published, or approved treatments change.

No spam. Unsubscribe anytime.